91-105 of 774
Clinical Outcomes of Radiation vs. Chemoradiation in Recurrent Endometrial Cancer
Advances in Women's HealthClinical Outcomes of Radiation vs. Chemoradiation in Recurrent Endometrial Cancer
Ibrutinib-Venetoclax in Relapsed CLL: MRD-Guided Approach Balances Efficacy and Safety
Project Oncology®Ibrutinib-Venetoclax in Relapsed CLL: MRD-Guided Approach Balances Efficacy and Safety
Prognostic Value of Red Cell Distribution Width at Ruxolitinib Initiation in Myelofibrosis
Project Oncology®Prognostic Value of Red Cell Distribution Width at Ruxolitinib Initiation in Myelofibrosis
Addressing Psychological Distress in Lung Cancer: The Emerging Role of EMDR Therapy
Project Oncology®Addressing Psychological Distress in Lung Cancer: The Emerging Role of EMDR Therapy
Targeting CCR4 in CAR-Associated Peripheral T-Cell Lymphoma
Project Oncology®Targeting CCR4 in CAR-Associated Peripheral T-Cell Lymphoma
Expanding Cancer Detection: How MCED Testing Complements Standard Screening
Project Oncology®Expanding Cancer Detection: How MCED Testing Complements Standard Screening
- advertisement
Long-Term Survival Data in High-Risk NSCLC: Insights from Real-World Practice
Project Oncology®Long-Term Survival Data in High-Risk NSCLC: Insights from Real-World Practice
Durable Outcomes in NSCLC: 6-Year Survival Findings from CheckMate 9LA
Project Oncology®Durable Outcomes in NSCLC: 6-Year Survival Findings from CheckMate 9LA
6-Year Outcomes from CheckMate 9LA: Efficacy and Safety Across NSCLC Subgroups
Project Oncology®6-Year Outcomes from CheckMate 9LA: Efficacy and Safety Across NSCLC Subgroups
Monitoring Adverse Events Post-CAR T: The Latest Approaches and Best Practices
Project Oncology®Monitoring Adverse Events Post-CAR T: The Latest Approaches and Best Practices
Monitoring Adverse Events Post-CAR T: The Latest Approaches and Best Practices
Project Oncology®Monitoring Adverse Events Post-CAR T: The Latest Approaches and Best Practices
Mutational Complexity in ROS1-Positive mNSCLC: Insights from Real-World Practice
Project Oncology®Mutational Complexity in ROS1-Positive mNSCLC: Insights from Real-World Practice
- advertisement
Rethinking Cancer Screening: The Rationale for Multi-Biomarker MCED Testing
Project Oncology®Rethinking Cancer Screening: The Rationale for Multi-Biomarker MCED Testing
Integrating MCED Testing in Practice: Best Practices for Enhancing Cancer Screening
Project Oncology®Integrating MCED Testing in Practice: Best Practices for Enhancing Cancer Screening
Immunotherapy Advances in Squamous Cell Anal Carcinoma: A New Standard of Care
Project Oncology®Immunotherapy Advances in Squamous Cell Anal Carcinoma: A New Standard of Care
